ProCE Banner Activity

Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

Podcast Episodes

Listen as expert faculty answer audience questions on the management of patients with T-cell lymphomas posed during a live symposium at the 2022 Hematology Annual Meeting.

Released: February 17, 2023

Expiration: February 16, 2024

No longer available for credit.

Share

Faculty

Steven M. Horwitz

Steven M. Horwitz, MD

Member, Memorial Sloan Kettering Cancer Center
Attending Physician, Memorial Hospital
Professor of Medicine, Weill Cornell Medical College
New York, New York

Pamela B. Allen

Pamela B. Allen, MD, MSc

Assistant Professor
Department of Hematology/Oncology
Emory University, Winship Cancer Institute
The Emory Clinic
Atlanta, Georgia

Kerry Savage

Kerry Savage, MD, MSc

Associate Professor
Department of Medicine, Division of Medical Oncology
Medical Oncologist
Department of Medical Oncology
British Columbia Cancer Agency
Vancouver, British Columbia, Canada

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo

Kyowa Kirin Inc

Seagen Inc.

Program Director Disclosure

Program Director

Steven M. Horwitz, MD

Member, Memorial Sloan Kettering Cancer Center
Attending Physician, Memorial Hospital
Professor of Medicine, Weill Cornell Medical College
New York, New York

Steven M. Horwitz, MD: consultant/advisor/speaker: Acrotech, C4 Therapeutics, Cimeio Therapeutics, Myeloid Therapeutics, Seattle Genetics, Shoreline Biosciences, Takeda, Tubulis, Vividion Therapeutics.

Faculty Disclosure

Primary Author

Pamela B. Allen, MD, MSc

Assistant Professor
Department of Hematology/Oncology
Emory University, Winship Cancer Institute
The Emory Clinic
Atlanta, Georgia

Pamela B. Allen, MD, MSc: consultant/advisor/speaker: ADC Therapeutics, Daiichi Sankyo, Epizyme, Kyowa Kirin, Secura Bio.

Kerry Savage, MD, MSc

Associate Professor
Department of Medicine, Division of Medical Oncology
Medical Oncologist
Department of Medical Oncology
British Columbia Cancer Agency
Vancouver, British Columbia, Canada

Kerry Savage, MD, MSc: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, Janssen, Merck, Novartis, Seagen; researcher: Bristol-Myers Squibb; steering committee: BeiGene; data and safety monitoring committee: Regeneron.